CONTACT US | Phone: 1-800-537-2790
  • COMPANY
    • OVERVIEW
    • QUALITY
    • CAREERS
  • PRODUCTS
    • RENUVION®
    • J-PLASMA®
    • PATENTS
    • SYMBOL GLOSSARY
    • Electronic IFU Portal
    • Electronic IFU Portal
  • INVESTOR RELATIONS
  • BLOG
  • COMPANY
    • OVERVIEW
    • QUALITY
    • CAREERS
  • PRODUCTS
    • RENUVION®
    • J-PLASMA®
    • PATENTS
    • SYMBOL GLOSSARY
    • Electronic IFU Portal
    • Electronic IFU Portal
  • INVESTOR RELATIONS
  • BLOG

Case Study

Home » Case Study
By apyxmedical
In 2020 Shareholder News, Case Study, J-Plasma, Renuvion
Posted November 23, 2020

APYX MEDICAL CORPORATION ANNOUNCES APPROVAL FROM FDA TO BEGIN PHASE II OF U.S. IDE STUDY

READ MORE
By apyxmedical
In 2020 Shareholder News, Case Study, J-Plasma, Renuvion
Posted November 9, 2020

APYX MEDICAL CORPORATION ANNOUNCES UPDATES ON U.S. IDE CLINICAL STUDIES

READ MORE

© Copyright 2024 Apyx Medical. All rights reserved. Renuvion®, J-Plasma® and Reshaping What's Possible® are registered trademarks of Apyx Medical Corporation. Bovie® is a registered trademark of Symmetry Surgical. Energy Elevating Lives℠ is a service mark of Apyx Medical Corporation. Apyx™ is a trademark of Apyx Medical Corporation.

Contact Us | Privacy Policy | Terms of Use | Disclaimer

Top
This site tracks visits anonymously. Visit our Privacy Policy page to learn more about the data we collect, and the cookies used on this site. If you agree with these policies, click the AGREE button to close this message.

AGREEPrivacy policy